AP9100332A0 - Vaccines - Google Patents

Vaccines

Info

Publication number
AP9100332A0
AP9100332A0 AP91/00332A AP9100332A AP9100332A0 AP 9100332 A0 AP9100332 A0 AP 9100332A0 AP 91/00332 A AP91/00332 A AP 91/00332A AP 9100332 A AP9100332 A AP 9100332A AP 9100332 A0 AP9100332 A0 AP 9100332A0
Authority
AP
ARIPO
Prior art keywords
vaccines
Prior art date
Application number
AP91/00332A
Other versions
AP368A (en
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of AP9100332A0 publication Critical patent/AP9100332A0/en
Application granted granted Critical
Publication of AP368A publication Critical patent/AP368A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1991/000332A 1991-03-21 1991-11-04 Derivatives of gp160 and vaccine based on gp160 or a derivative thereof, containing an adjuvant. AP368A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919106048A GB9106048D0 (en) 1991-03-21 1991-03-21 Vaccines

Publications (2)

Publication Number Publication Date
AP9100332A0 true AP9100332A0 (en) 1992-01-31
AP368A AP368A (en) 1994-10-28

Family

ID=10691984

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1991/000332A AP368A (en) 1991-03-21 1991-11-04 Derivatives of gp160 and vaccine based on gp160 or a derivative thereof, containing an adjuvant.

Country Status (12)

Country Link
CN (1) CN1064891A (en)
AP (1) AP368A (en)
BR (1) BR9107294A (en)
CZ (1) CZ195793A3 (en)
FI (1) FI934133A0 (en)
GB (1) GB9106048D0 (en)
HU (2) HU9302642D0 (en)
IL (1) IL99899A0 (en)
MA (1) MA22381A1 (en)
SK (1) SK82593A3 (en)
WO (1) WO1992016556A1 (en)
YU (1) YU174491A (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9105992D0 (en) * 1991-03-21 1991-05-08 Smithkline Beecham Biolog Vaccine
US6620414B2 (en) 1992-03-27 2003-09-16 Smithkline Beecham Biologicals (S.A.) Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
JP4028593B2 (en) * 1993-03-23 2007-12-26 グラクソスミスクライン・バイオロジカルス・ソシエテ・アノニム 3-O deacylated monophosphoryl lipid A-containing vaccine composition
GB9326253D0 (en) 1993-12-23 1994-02-23 Smithkline Beecham Biolog Vaccines
GB9706957D0 (en) 1997-04-05 1997-05-21 Smithkline Beecham Plc Formulation
GB9820525D0 (en) 1998-09-21 1998-11-11 Allergy Therapeutics Ltd Formulation
GB0000891D0 (en) 2000-01-14 2000-03-08 Allergy Therapeutics Ltd Formulation
CN1304580C (en) * 2004-07-09 2007-03-14 楼伟 Surface glucoprotein gp160 of recombination expression human acquired immunity defact virus 1
DE602005025647D1 (en) * 2004-07-23 2011-02-10 Novartis Vaccines & Diagnostic POLYPEPTIDES FOR THE OLIGOMERIZATION OF ANTIGENES
BR122016029840B1 (en) 2004-09-22 2021-10-13 Glaxosmithkline Biologicals S.A. IMMUNOGENIC COMPOSITION, METHOD OF MAKING AN IMMUNOGENIC COMPOSITION, AND, USE OF IMMUNOGENIC COMPOSITION
WO2008104803A2 (en) 2007-02-26 2008-09-04 Oxford Genome Sciences (Uk) Limited Proteins
EP2447719B1 (en) 2007-02-26 2016-08-24 Oxford BioTherapeutics Ltd Proteins
US20120058131A1 (en) 2009-01-21 2012-03-08 Oxford Biotherapeutics Ltd Pta089 protein
US20120282177A1 (en) 2009-11-02 2012-11-08 Christian Rohlff ROR1 as Therapeutic and Diagnostic Target
RS55716B1 (en) 2011-06-28 2017-07-31 Oxford Biotherapeutics Ltd THERAPY AND DIAGNOSTIC OBJECTIVE
GB201213364D0 (en) 2012-07-27 2012-09-12 Glaxosmithkline Biolog Sa Purification process
GB201213652D0 (en) 2012-08-01 2012-09-12 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
GB201302447D0 (en) 2013-02-12 2013-03-27 Oxford Biotherapeutics Ltd Therapeutic and diagnostic target
WO2016154010A1 (en) 2015-03-20 2016-09-29 Makidon Paul Immunogenic compositions for use in vaccination against bordetella
CN109310773B (en) 2016-05-16 2022-04-26 传染病研究所 Formulations containing TLR agonists and methods of use
IL319503A (en) 2016-05-16 2025-05-01 Access To Advanced Health Inst Pegylated liposomes and methods of use
AU2022249423A1 (en) * 2021-03-30 2023-11-09 Baylor College Of Medicine Methods and compositions for high-potency polypeptide-based protein inhibition

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein

Also Published As

Publication number Publication date
HUT67011A (en) 1995-01-30
CN1064891A (en) 1992-09-30
IL99899A0 (en) 1992-08-18
HU9302642D0 (en) 1994-01-28
SK82593A3 (en) 1994-01-12
FI934133L (en) 1993-09-21
AP368A (en) 1994-10-28
WO1992016556A1 (en) 1992-10-01
MA22381A1 (en) 1992-07-01
FI934133A7 (en) 1993-09-21
YU174491A (en) 1994-06-10
GB9106048D0 (en) 1991-05-08
FI934133A0 (en) 1993-09-21
CZ195793A3 (en) 1994-05-18
BR9107294A (en) 1994-06-14

Similar Documents

Publication Publication Date Title
ZA922011B (en) Vaccine
HU9202436D0 (en) Vaccines
AP9300541A0 (en) Vaccines
AP9300530A0 (en) Vaccines
IL99899A0 (en) Vaccines
GB9215233D0 (en) Vaccines
GB9201023D0 (en) Vaccines
GB9202933D0 (en) Vaccines
GB9214871D0 (en) Vaccines
GB9213559D0 (en) Vaccines
GB9226768D0 (en) Vaccines
GB9124390D0 (en) Vaccines
GB9110067D0 (en) Vaccines
GB9105993D0 (en) Vaccines
GB9121208D0 (en) Vaccines
GB9119167D0 (en) Vaccines
GB9119009D0 (en) Vaccines
ZA926088B (en) Vaccines
GB9211081D0 (en) Vaccines
GB9006097D0 (en) Vaccines
GB9011358D0 (en) Vaccines
GB9217635D0 (en) Vaccines
ZA935281B (en) Vaccines
GB9221891D0 (en) Vaccines
GB9211318D0 (en) Vaccines